Primary Recipient

KENTUCKY PHARMACEUTICALS, INC.

Amount

$199,998.00

Award Date

4/08/2010

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

The overall goal of this project is to develop the lateral flow assay for detecting complement levels and complement activation status in a patient. This assay will give results in seconds versus either hours or days that normal complement lab assays have